17-80118282-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000152.5(GAA):​c.2571G>T​(p.Leu857Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000532 in 1,603,306 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L857L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0029 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 2 hom. )

Consequence

GAA
NM_000152.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.538

Publications

1 publications found
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GAA Gene-Disease associations (from GenCC):
  • glycogen storage disease II
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, G2P
  • glycogen storage disease due to acid maltase deficiency, infantile onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • glycogen storage disease due to acid maltase deficiency, late-onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 17-80118282-G-T is Benign according to our data. Variant chr17-80118282-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 382786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.538 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00295 (449/152314) while in subpopulation AFR AF = 0.0104 (432/41578). AF 95% confidence interval is 0.00958. There are 3 homozygotes in GnomAd4. There are 199 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
NM_000152.5
MANE Select
c.2571G>Tp.Leu857Leu
synonymous
Exon 18 of 20NP_000143.2
GAA
NM_001079803.3
c.2571G>Tp.Leu857Leu
synonymous
Exon 19 of 21NP_001073271.1
GAA
NM_001079804.3
c.2571G>Tp.Leu857Leu
synonymous
Exon 18 of 20NP_001073272.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
ENST00000302262.8
TSL:1 MANE Select
c.2571G>Tp.Leu857Leu
synonymous
Exon 18 of 20ENSP00000305692.3
GAA
ENST00000390015.7
TSL:1
c.2571G>Tp.Leu857Leu
synonymous
Exon 19 of 21ENSP00000374665.3
GAA
ENST00000933406.1
c.2586G>Tp.Leu862Leu
synonymous
Exon 18 of 20ENSP00000603465.1

Frequencies

GnomAD3 genomes
AF:
0.00293
AC:
446
AN:
152196
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0103
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000805
AC:
195
AN:
242180
AF XY:
0.000580
show subpopulations
Gnomad AFR exome
AF:
0.0115
Gnomad AMR exome
AF:
0.000121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000346
GnomAD4 exome
AF:
0.000278
AC:
404
AN:
1450992
Hom.:
2
Cov.:
35
AF XY:
0.000236
AC XY:
170
AN XY:
720690
show subpopulations
African (AFR)
AF:
0.0110
AC:
364
AN:
33218
American (AMR)
AF:
0.000161
AC:
7
AN:
43468
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25318
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39526
South Asian (SAS)
AF:
0.0000118
AC:
1
AN:
85040
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52792
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5710
European-Non Finnish (NFE)
AF:
0.00000452
AC:
5
AN:
1106084
Other (OTH)
AF:
0.000435
AC:
26
AN:
59836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00295
AC:
449
AN:
152314
Hom.:
3
Cov.:
32
AF XY:
0.00267
AC XY:
199
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0104
AC:
432
AN:
41578
American (AMR)
AF:
0.000784
AC:
12
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68010
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00169
Hom.:
0
Bravo
AF:
0.00336
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Glycogen storage disease, type II (3)
-
-
2
not provided (2)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
2.2
DANN
Benign
0.57
PhyloP100
0.54
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17853996; hg19: chr17-78092081; API